Journal of Brain and Neurology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

MYRICETIN REDUCES TOXIC LEVEL OF CAG REPEATS RNA IN HUNTINGTON’S DISEASE (HD) AND SPINOCEREBELLAR ATAXIA (SCAS)

3rd International Conference on NEUROLOGY AND BRAIN DISORDERS
June 19-20, 2019 | Dublin, Ireland

Eshan Khan, Subodh Kumar Mishra and Amit Kumar

Indian Institute of Technology, India

Scientific Tracks Abstracts : J Brain Neurol

Abstract:

Huntington’s disease (HD) is a neurodegenerative disorder that is caused by abnormal expansion of CAG repeats in the HTT gene. The transcribed mutant RNA contains expanded CAG repeats that translate into a mutant huntingtin protein. This expanded CAG repeat also causes mis-splicing of pre-mRNA due to sequestration of muscle blind like-1 splicing factor (MBNL1) and thus both of these elicit the pathogenesis of HD. Targeting the onset as well as progression of HD by small molecules could be a potent therapeutic approach. Author has screened a set of small molecules to target this transcript and found Myricetin, a flavonoid as a lead molecule that interacts with the CAG motif and thus prevents the translation of mutant huntingtin protein as well as sequestration of MBNL1. Here, they report the first solution structure of the complex formed between Myricetin and RNA containing the 5’CAG/3’GAC motif. Myricetin interacts with this RNA via base stacking at the AA mismatch. Moreover, Myricetin was also found reducing the proteo-toxicity generated due to the aggregation of polyglutamine and further, its supplementation also improves neurobehavioral deficits in the HD mouse model. Their study provides the structural and mechanistic basis of Myricetin as an effective therapeutic candidate for HD and other polyQ related disorders.

Biography:

Eshan Khan is a PhD Research Scholar under supervision of Dr Amit Kumar in Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, India. He has joined Amit Kumar’s lab in July, 2014 and working on therapeutic approaches targeting (CAG) exp RNA that causes neurological disorders like Huntington’s disease (HD) and Spino cerebellar ataxia (SCAs).

E-mail: phd1401171001@iiti.ac.in

PDF HTML
Get the App